Status:
COMPLETED
Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion
Lead Sponsor:
GlaxoSmithKline
Conditions:
Nasal Congestion
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of the study is to evaluate the effect of the nasal strip (relative to the placebo strip) on the nasal passages using anatomical MRI scans and to demonstrate the effect of the strip on breathi...
Eligibility Criteria
Inclusion
- Participants with a self-rating of at least 3 to 8 for nasal congestion on the numerical rating scale
- Participants with a nasal congestion frequency score of 1, 2, 3 or 4.
Exclusion
- Evidence of obstructive nasal polyps, nasal tract structural malformations, visible open sores, sunburn, irritation, eczema or chronic skin condition on the face or nose
- Use of any medications like nasal decongestant, alpha adrenergic drugs, glucocorticoids and any current treatment which in the opinion of the investigator will affect nasal congestion
- Known or suspected intolerance or hypersensitivity to the study materials.
Key Trial Info
Start Date :
August 5 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2013
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT02275364
Start Date
August 5 2013
End Date
October 30 2013
Last Update
August 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imanova Centre for Imaging Sciences
London, United Kingdom, W12 0NN